Literature DB >> 3487648

Familial abnormalities of lymphocyte function in a large Sjögren's syndrome kindred.

D A Jabs, F C Arnett, W B Bias, M G Beale.   

Abstract

A large kindred (32 members), whose proband had primary Sjögren's syndrome, was investigated to ascertain whether abnormalities of lymphocyte function were present in family members of patients with Sjögren's syndrome. Ten members of the kindred with autoimmune diseases, 17 blood relatives, 5 spouses, and 32 matched controls were studied. Concanavalin A induced suppression of pokeweed mitogen stimulated immunoglobulin synthesis was decreased in patients and blood relatives both with and without autoimmune diseases. Elevations of the mean T4/T8 ratio, due to decreased numbers of suppressor/cytotoxic lymphocytes, were present in both the disease group and the blood relatives. These abnormalities occurred independently of HLA and were not necessarily associated with autoantibodies.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3487648

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Abnormal galactosylation of serum IgG in patients with systemic lupus erythematosus and members of families with high frequency of autoimmune diseases.

Authors:  M Tomana; R E Schrohenloher; J D Reveille; F C Arnett; W J Koopman
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

2.  Decreased CD8+ T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes.

Authors:  Michael P Pender; Peter A Csurhes; Casey M M Pfluger; Scott R Burrows
Journal:  BMC Neurol       Date:  2011-08-03       Impact factor: 2.474

3.  CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis.

Authors:  Michael P Pender
Journal:  Autoimmune Dis       Date:  2012-01-24

4.  Immune function in X-linked retinoschisis subjects in an AAV8-RS1 phase I/IIa gene therapy trial.

Authors:  Alaknanda Mishra; Camasamudram Vijayasarathy; Catherine A Cukras; Henry E Wiley; H Nida Sen; Yong Zeng; Lisa L Wei; Paul A Sieving
Journal:  Mol Ther       Date:  2021-02-15       Impact factor: 12.910

5.  Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis.

Authors:  Michael P Pender; Peter A Csurhes; Jacqueline M Burrows; Scott R Burrows
Journal:  Clin Transl Immunology       Date:  2017-01-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.